International consensus statement on allergy and rhinology: Allergic rhinitis – 2023
International Forum of Allergy & Rhinology · 2023-04 · 13 (4) · 293-859
DOI: 10.1002/alr.23090 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Forum of Allergy & Rhinology, online erschienen am 06.03.2023. Verfasst von Sarah K Wise und 59 weiteren Autor:innen. Beteiligte Einrichtung: Otolaryngology-HNS, Emory University, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Iron-Dextran Complex, Rhinitis, Allergic. Die Arbeit wurde bisher 499-mal zitiert (Crossref) und nennt 3440 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Medical Research Council.
Abstract (Originalsprache)
Background
In the 5 years that have passed since the publication of the 2018 International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR‐Allergic Rhinitis 2018), the literature has expanded substantially. The ICAR‐Allergic Rhinitis 2023 update presents 144 individual topics on allergic rhinitis (AR), expanded by over 40 topics from the 2018 document. Originally presented topics from 2018 have also been reviewed and updated. The executive summary highlights key evidence‐based findings and recommendation from the full document.
Methods
ICAR‐Allergic Rhinitis 2023 employed established evidence‐based review with recommendation (EBRR) methodology to individually evaluate each topic. Stepwise iterative peer review and consensus was performed for each topic. The final document was then collated and includes the results of this work.
Results
ICAR‐Allergic Rhinitis 2023 includes 10 major content areas and 144 individual topics related to AR. For a substantial proportion of topics included, an aggregate grade of evidence is presented, which is determined by collating the levels of evidence for each available study identified in the literature. For topics in which a diagnostic or therapeutic intervention is considered, a recommendation summary is presented, which considers the aggregate grade of evidence, benefit, harm, and cost.
Conclusion
The ICAR‐Allergic Rhinitis 2023 update provides a comprehensive evaluation of AR and the currently available evidence. It is this evidence that contributes to our current knowledge base and recommendations for patient evaluation and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Otolaryngology-HNS, Emory University, Atlanta, Georgia, USA.
- Otolaryngology-HNS, Private Practice, University of Central Florida, Lake Mary, Florida, USA.
- Otolaryngology-HNS, Washington University, St. Louis, Missouri, USA.
- Otolaryngology-HNS, University of North Carolina, Chapel Hill, North Carolina, USA.
- Otolaryngology-HNS, University of Wisconsin, Madison, Wisconsin, USA.
- Otolaryngology-HNS, McGovern Medical School of the University of Texas, Houston, Texas, USA.
ORCID-Profile: Lauren T Roland, Joshua M Levy, Amber Luong, Ahmad R Sedaghat, Jennifer Villwock, Baharudin Abdullah, Jeremiah A Alt, Mohamad R Chaaban, Amarbir Gill, Merin Elizabeth Kuruvilla, Jean Kim, Edward C Kuan, Victoria S Lee, Sonya Marcus, Jose Mattos, Edward McCoul, Jayakar V Nayak
Förderung
- Medical Research Council
Zitieren
APA
Wise, S. K., Damask, C., Roland, L. T., Ebert, C., Levy, J. M., Lin, S., Luong, A., Rodriguez, K., Sedaghat, A. R., Toskala, E., Villwock, J., Abdullah, B., Akdis, C., Alt, J. A., Ansotegui, I. J., Azar, A., Baroody, F., Benninger, M. S., Bernstein, J., …, & Nayak, J. V. (2023). International consensus statement on allergy and rhinology: Allergic rhinitis – 2023. International Forum of Allergy & Rhinology, 13(4), 293-859. https://doi.org/10.1002/alr.23090
Vancouver
Wise SK, Damask C, Roland LT, Ebert C, Levy JM, Lin S, et al. International consensus statement on allergy and rhinology: Allergic rhinitis – 2023. International Forum of Allergy & Rhinology. 2023;13(4):293-859. doi:10.1002/alr.23090
BibTeX
@article{Wise2023,
author = {Wise, Sarah K and Damask, Cecelia and Roland, Lauren T and Ebert, Charles and Levy, Joshua M and Lin, Sandra and Luong, Amber and Rodriguez, Kenneth and Sedaghat, Ahmad R and Toskala, Elina and Villwock, Jennifer and Abdullah, Baharudin and Akdis, Cezmi and Alt, Jeremiah A and Ansotegui, Ignacio J and Azar, Antoine and Baroody, Fuad and Benninger, Michael S and Bernstein, Jonathan and Brook, Christopher and Campbell, Raewyn and Casale, Thomas and Chaaban, Mohamad R and Chew, Fook Tim and Chambliss, Jeffrey and Cianferoni, Antonella and Custovic, Adnan and Davis, Elizabeth Mahoney and DelGaudio, John M and Ellis, Anne K and Flanagan, Carrie and Fokkens, Wytske J and Franzese, Christine and Greenhawt, Matthew and Gill, Amarbir and Halderman, Ashleigh and Hohlfeld, Jens M and Incorvaia, Cristoforo and Joe, Stephanie A and Joshi, Shyam and Kuruvilla, Merin Elizabeth and Kim, Jean and Klein, Adam M and Krouse, Helene J and Kuan, Edward C and Lang, David and Larenas-Linnemann, Desiree and Laury, Adrienne M and Lechner, Matt and Lee, Stella E and Lee, Victoria S and Loftus, Patricia and Marcus, Sonya and Marzouk, Haidy and Mattos, Jose and McCoul, Edward and Melen, Erik and Mims, James W and Mullol, Joaquim and Nayak, Jayakar V},
title = {International consensus statement on allergy and rhinology: Allergic rhinitis – 2023},
journal = {International Forum of Allergy & Rhinology},
year = {2023},
volume = {13},
number = {4},
pages = {293--859},
doi = {10.1002/alr.23090}
}
EUVIMED